Loading...
Loading...
All product recalls associated with Nutraceutical Corporation, of Salt Lake City, Utah.
Total Recalls
1000
Past Year
53
Class I (Serious)
166
Most Recent
Dec 2025
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
This recall involves Solaray Liposomal Women's in 60 and 120 count, Solaray Universal Multivitamin in 60 and 120 count, and Solaray Liposomal Women's 50+ Multivitamin in 120 count. The bottles are a clear silver color with white pop top lids. The white label on the front of the bottles displays the Solaray logo, product name, product type and size count. The 60 count bottles are contained in cartons, which are substantially similar in appearance to the bottles inside. All lots are included in the recall. Name Count SKU Solaray Liposomal Women's 60 076280193251 Solaray Liposomal Women's 120 076280339536 Solaray Universal Multivitamin 60 076280640168 Solaray Universal Multivitamin 120 076280830385 Solaray Liposomal Women's 50+ Multivitamin 120 076280154832
The firm has identified that the Transferrin reagent does not meet the Instructions for Use (IFU) reagent on-board stability claims, which may cause control failures and/or erroneous patient samples results. The Complaint handling unit has received a total of 2 safety cases (CASE-2023-02027212 and CASE-2023-02045278) and 99 quality cases with the failure mode attributed to Transferrin reagent (OSR6152 / lot 2573) associated with reagent blank shifts for the Reagent 2 (R2), imprecision, calibration failures, erratic Quality Control (QC) recoveries, and/or erroneous high/low (serum, plasma, urine) patient results. The issue was confirmed through internal testing by Beckman Coulter on June 30, 2023. Reagent Blank shifts for R2, imprecision, calibration failures, erratic Quality Control (QC) recoveries, and/or erroneous high/low (serum, plasma, urine) patient results. The issue was confirmed through internal testing by Beckman Coulter on June 30, 2023.